Scott Szymanski

Scott Szymanski has extensive work experience in various pharmaceutical and healthcare companies. Scott has held several leadership roles throughout their career, starting in 2005 at Valeant Pharmaceuticals as the National Sales Director. From there, they worked at Merz Therapeutics as the National Sales Director and Sr Director Market Development/New Product Planning. Scott then moved on to Zogenix, Inc. as the National Sales and Marketing Director-Director Trade Relations. Following that, they worked at Pernix Therapeutics and Currax Pharmaceuticals LLC as the Sr Director of Commercial Operations for both companies, focusing on migraine and pain. In 2019, they became the President and CCO of Theranica Bio-Electronics Ltd., overseeing the US division. Later in 2019, they joined ProCare Rx as the Sr Vice President of Business Development. Scott then worked at DTxCC (Digital Therapeutics Commercialization Consultants, LLC) as a Sr Advisor in Commercial Strategy. Most recently, they joined Syneos Health as the Commercial Lead/Head of Commercial for Anti-Infective/Migraine.

In 2023, they will begin working at Tonix Pharmaceuticals as the VP of Sales and Marketing for Migraine.

Scott Szymanski has a Bachelor of Science (BS) degree from the United States Naval Academy. Scott also obtained an MBA from the University of Connecticut School of Business. Additionally, they completed Naval Flight School.